← World Journal of Gastrointestinal Pharmacology and Therapeutics

Papers in World Journal of Gastrointestinal Pharmacology and Therapeutics

Page 3 · newest first

101. Nanomaterials: Applications in the diagnosis and treatment of pancreatic cancerWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2020
102. Case Control Study Risk factors for recurrence after bowel resection for Crohn’s diseaseWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2019
103. Nutritional status as a predictor of hospitalization in inflammatory bowel disease: A reviewWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2019
104. Crohn’s disease of esophagus, stomach and duodenumWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2019
105. Update on the management of gastrointestinal varicesWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2019
106. Opioid use and misuse in ulcerative colitisWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2019
107. Potassium-competitive acid blockers - are they the next generation of proton pump inhibitors?World Journal of Gastrointestinal Pharmacology and Therapeutics · 2018
108. Coeliac disease in the modern era: Severity of small bowel mucosal injury at diagnosis with analysis of clinical correlates and rate of improvement on a gluten free dietWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2018
109. Endoscopic ultrasound guided gallbladder drainage - is it ready for prime time?World Journal of Gastrointestinal Pharmacology and Therapeutics · 2018
110. Challenges in the management of pancreatic exocrine insufficiencyWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2018
111. Colorectal cancer screening use among insured adults: Is out-of-pocket cost a barrier to routine screening?World Journal of Gastrointestinal Pharmacology and Therapeutics · 2018
112. Blood glucose response after oral intake of lactulose in healthy volunteers: A randomized, controlled, cross-over studyWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2018
113. Monitoring inflammatory bowel disease during pregnancy: Current literature and future challengesWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2018
114. Protozoan parasites in irritable bowel syndrome: A case-control studyWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2017
115. Association of miR-146 rs2910164, miR-196a rs11614913, miR-221 rs113054794 and miR-224 rs188519172 polymorphisms with anti-TNF treatment response in a Greek population with Crohn’s diseaseWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2017
116. Pathogenic mechanisms of pancreatitisWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2017
117. Phage therapy: An alternative to antibiotics in the age of multi-drug resistanceWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2017
118. Management of esophageal caustic injuryWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2017
119. Current practice and clinicians’ perception of medication non-adherence in patients with inflammatory bowel disease: A survey of 98 cliniciansWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2017
120. Role of clinical pathway in improving the quality of care for patients with faecal incontinence: A randomised trialWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2017
121. Psychotropic drugs and liver disease: A critical review of pharmacokinetics and liver toxicityWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2017
122. Correlation of rapid point-of-care vs send-out fecal calprotectin monitoring in pediatric inflammatory bowel diseaseWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2017
123. Inflammatory bowel disease: Efficient remission maintenance is crucial for cost containmentWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2017
124. Combination therapy for inflammatory bowel diseaseWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2017
125. Update on clinical and research application of fecal biomarkers for gastrointestinal diseasesWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2017
126. Itopride for gastric volume, gastric emptying and drinking capacity in functional dyspepsiaWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2017
127. Strategies for overcoming anti-tumor necrosis factor drug antibodies in inflammatory bowel disease: Case series and review of literatureWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2017
128. Clinical and economic impact of infliximab one-hour infusion protocol in patients with inflammatory bowel diseases: A multicenter studyWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2017
129. Lymphocyte-to-monocyte ratio can predict mortality in pancreatic adenocarcinomaWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2017
130. Tryptophan: A gut microbiota-derived metabolites regulating inflammationWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2017
131. Plecanatide-mediated activation of guanylate cyclase-C suppresses inflammation-induced colorectal carcinogenesis in Apc+/Min-FCCCmiceWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2017
132. Interferon-free treatments in patients with hepatitis C genotype 1-4 infections in a real-world settingWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2017
133. Critically ill patients and gut motility: Are we addressing it?World Journal of Gastrointestinal Pharmacology and Therapeutics · 2017
134. Low dose oral curcumin is not effective in induction of remission in mild to moderate ulcerative colitis: Results from a randomized double blind placebo controlled trialWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2017
135. Thiol/disulphide homeostasis in celiac diseaseWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2017
136. Diagnosis and management of functional symptoms in inflammatory bowel disease in remissionWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2016
137. Overview of cytokines and nitric oxide involvement in immuno-pathogenesis of inflammatory bowel diseasesWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2016
138. Widespread use of gastric acid inhibitors in infants: Are they needed? Are they safe?World Journal of Gastrointestinal Pharmacology and Therapeutics · 2016
139. Review of efficacy and safety of laxatives use in geriatricsWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2016
140. Eosinophilic gastroenteritis: Approach to diagnosis and managementWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2016
141. Predictive factors for a severe clinical course in ulcerative colitis: Results from population-based studiesWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2016
142. Transoral incisionless fundoplication for gastro-esophageal reflux disease: Techniques and outcomesWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2016
143. Therapeutic effect of melatonin on pediatric functional dyspepsia: A pilot studyWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2016
144. Good adherence to mediterranean diet can prevent gastrointestinal symptoms: A survey from Southern ItalyWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2016
145. Barrett’s esophagus in 2016: From pathophysiology to treatmentWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2016
146. Clinical significance and management of Barrett’s esophagus with epithelial changes indefinite for dysplasiaWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2016
147. Efficacy of small-volume simethicone given at least 30 min before gastroscopyWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2016
148. Emerging role of novel biomarkers in the diagnosis of inflammatory bowel diseaseWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2016
149. Incidence of leukopenia after intraperitonealvscombined intravenous/intraperitoneal chemotherapy in pseudomyxoma peritoneiWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2016
150. Faecal incontinence and health related quality of life in inflammatory bowel disease patients: Findings from a tertiary care center in South AsiaWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2016